At a glance
- Originator Unknown
- Developer Nonindustrial source
- Class Antiarrhythmics; Antihypertensives
- Mechanism of Action Alpha adrenergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Arrhythmias
Most Recent Events
- 17 Nov 2003 Discontinued - Preclinical for Arrhythmias in France (unspecified route)
- 17 Nov 2003 Discontinued - Preclinical for Arrhythmias in Poland (unspecified route)
- 10 Dec 1998 Preclinical development for Arrhythmias in France (Unknown route)